HGF, produced by a large number of tumors, such as carcinomas, soft tissue sarcoma, and hematopoietic malignancies, is implicated in tumor angiogenesis [19], while its receptor c-met is not only expressed by diverse tumor cells, but also present on the surface of immune cells such as DCs [20]. Here, HGF is linked to neoplasm.